Aptargroup, Inc. ATR
Aptar is a global leader in the design and manufacturing of drug and consumer product dosing, dispensing and protection technologies. 10-K, Item 1
- Headquarters
- Crystal Lake, IL
- CEO
- Gael Touya
- Next results
- around Feb 4, 2027
ATR among Materials peers
Six ratios from the latest 10-K. Each corner is the share of 84 peers the company is above, not a score.
What changed
7 new risk paragraphs and 2 accounting facts worth reading about. 10-K filed Feb 6, 2026 against Feb 7, 2025.
Each row opens the detail with the quote and the filing. A row is a change worth reading, not a verdict.
Accounting checks
11 checks on the latest 10-K. Checks, not verdicts.
2facts worth reading about the other 9 checks found nothing to note
-
Receivables growing faster than revenueReceivables +22.2% ($658.1M to $803.8M) vs revenue +5.4% ($3.6B to $3.8B), +16.7 pts apart
-
Inventory growing faster than revenueInventory +16.5% ($461.8M to $537.8M) vs revenue +5.4% ($3.6B to $3.8B), +11.0 pts apart
-
Cash from operations $570.0M vs net income $392.8M (FY ending Dec 31, 2025)
8 more checks with nothing to note
-
Same auditor in both 10-Ks: PricewaterhouseCoopers LLP
-
No statement of substantial doubt about going concern
-
No 8-K item 4.02 in the last 2 years
-
No NT 10-K or NT 10-Q in the last 2 years
-
No longer listed: Table of Contents. Same as last year: Goodwill Impairment Assessment - Beauty Reporting Unit; Revenue Recognition - Product Sales
-
No sentence in the 10-K concludes that controls were not effective because of a material weakness
-
No 8-K item 2.06 in the last 2 years
-
No 8-K item 1.03 in the last 2 years
In their words
7 paragraphs in Risk Factors that were not in the 10-K filed Feb 7, 2025. Quoted as filed.
-
Item 1A · new paragraph · not in the 10-K filed Feb 7, 2025 10-K, ITEM 1A
The rapid evolution and increased adoption of artificial intelligence technologies may intensify our cybersecurity risks. In addition, as locally hosted information technology environments and data centers continue to decline or are decommissioned,we may increasingly rely on cloud-based solutions to host applications and data. Any…
-
Item 1A · new paragraph · not in the 10-K filed Feb 7, 2025 10-K, ITEM 1A
A material failure or disruption at one or more of our manufacturing facilities could adversely affect our ability to generate sales and meet customer demand. Our ability to generate sales and meet customer demand depends on the continued operation of our manufacturing facilities, many of which involve complex, specialized, and highly…
-
Item 1A · new paragraph · not in the 10-K filed Feb 7, 2025 10-K, ITEM 1A
We are exposed to risks from lawsuits and claims, including product liability claims, as well as investigations, audits and other proceedings, which may result in substantial costs and expenses or interruption of our normal business operations. We are subject to a number of lawsuits and claims that arise in the ordinary course of our…
-
Item 1A · new paragraph · not in the 10-K filed Feb 7, 2025 10-K, ITEM 1A
We are also from time to time subject to claims from third parties suggesting that we may be infringing on their intellectual property rights. For example, in May 2025, Nemera filed patent infringement actions against us in France and Germany relating to certain of our ophthalmic products. In October 2025, an EPO hearing invalidated…
New risk paragraphs, against peers
Latest 10-K of each, Materials companies closest in revenue
Paragraphs in Risk Factors with nothing like them in the company's 10-K the year before. A count of text, not of risk.
Financial performance
Last 4 fiscal years · 10-K XBRL
| Metric | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Revenue | $3.3B | $3.5B | $3.6B | $3.8B |
| Net income | $239.3M | $284.5M | $374.5M | $392.8M |
| Operating cash flow | $478.6M | $575.2M | $643.4M | $570.0M |
| Free cash flow | $168.2M | $262.9M | $366.9M | $299.6M |
Revenue, FY2016 to FY2025
Ten fiscal years, each from its own 10-K · XBRL · USD
$3.8B ▲ 5.4% in FY2025$392.8M ▲ 4.9% in FY2025$299.6M ▼ 18.4% in FY2025
Recent filings
3 filings in the last 30 days · SEC EDGAR
-
Planned saleNov 2, 2026Prieur Marc (Officer) gave notice of a planned sale of 2,000 shares worth about $274K Form 144, approximate sale date Nov 2, 2026
-
10-QOct 30, 2026Quarterly report (10-Q) period ended Sep 30, 2026
-
8-KOct 29, 2026Quarterly results 8-K item 2.02
About the company
Aptargroup, Inc., Crystal Lake, IL · from the 10-K filed Feb 6, 2026
Aptar is a global leader in the design and manufacturing of drug and consumer product dosing, dispensing and protection technologies. Aptar serves diversified end markets including pharmaceutical, fragrance, facial skincare, color cosmetics, food, beverage, personal care and home care. Using proprietary design, engineering, materials science, and manufacturing capabilities, Aptar supports customers across these end markets by enabling safe, functional, and differentiated product and service delivery. Aptar is headquartered in Crystal Lake, Illinois and has approximately 14,000 employees in approximately 20 different countries. For more information, visit www.aptar.com.
- Headquarters
- Crystal Lake, IL
- Country
- United States
- Reports in
- USD
- Listed on
- NYSE
- Fiscal year ends
- December 31
- Last results
- Oct 29, 2026
- Incorporated in
- DE
Email alerts
Sources
The 10-K filed Feb 6, 2026 (open at SEC), compared with the 10-K filed Feb 7, 2025. Numbers from the XBRL of the 10-Ks; filings from SEC EDGAR.
Work with it: Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/ATR/export.csv") into a cell.